Notice: This company has been marked as potentially delisted and may not be actively trading. Sio Gene Therapies (SIOX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Sio Gene Therapies Inc (OTC:SIOX) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comSio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per ShareFebruary 2, 2024 | finance.yahoo.comSio Gene Therapies Inc SIOXNovember 22, 2023 | morningstar.comTwo Promising Gene Therapy Stocks Tackling Eye DiseaseNovember 1, 2023 | thestreet.comSio Gene Therapies (NASDAQ: AXGT)July 19, 2023 | fool.comRoivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 BillionJuly 13, 2023 | finance.yahoo.comA new gene therapy could be a game-changer for patients with severe anemia. The cost? $2.8 million.May 23, 2023 | nbcnews.comSio Gene Therapies Announces Fiscal Third Quarter 2022 Financial ResultsFebruary 14, 2023 | finance.yahoo.comSIOX Sio Gene Therapies Inc.January 26, 2023 | seekingalpha.comSio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and DissolutionDecember 14, 2022 | finance.yahoo.comFollowing layoffs, gene therapy firm leaves DurhamNovember 10, 2022 | bizjournals.comSio Gene Therapies Announces Fiscal Second Quarter 2022 Financial ResultsNovember 10, 2022 | finance.yahoo.comSio Gene Therapies (NASDAQ:SIOX) Will Have To Spend Its Cash WiselyOctober 31, 2022 | finance.yahoo.comSio Gene Therapies Announces Fiscal First Quarter 2022 Financial ResultsAugust 11, 2022 | finance.yahoo.comSio Gene Therapies Inc. (SIOX)August 5, 2022 | uk.finance.yahoo.comGene therapy firm in Durham slashes headcount as biotech stumblesJune 14, 2022 | bizjournals.comSio Gene Therapies Announces Fiscal Year 2021 Year-End Financial ResultsJune 14, 2022 | finance.yahoo.comMid-Afternoon Market Update: Nasdaq Jumps 400 Points; Sio Gene Therapies Shares PlummetApril 28, 2022 | markets.businessinsider.comSio Gene Therapies Ditches Two Remaining Programs, Seeks Buyer(s), Shares PlungeApril 28, 2022 | finance.yahoo.comSio Gene Therapies Provides Corporate UpdateApril 27, 2022 | finance.yahoo.comSio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial ResultsFebruary 11, 2022 | finance.yahoo.comSVB Leerink Downgrades Sio Gene Therapies to Market Perform, Lowers Price Target to $1February 2, 2022 | benzinga.comHC Wainwright & Co. Maintains Buy on Sio Gene Therapies, Lowers Price Target to $7February 1, 2022 | benzinga.comThe Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's ProgramFebruary 1, 2022 | msn.comZacks Investment Research Upgrades Sio Gene Therapies (NASDAQ:SIOX) to "Hold"Zacks Investment Research raised shares of Sio Gene Therapies from a "sell" rating to a "hold" rating in a report on Tuesday.January 18, 2022 | marketbeat.comSio Gene Therapies Inc. (NASDAQ:SIOX) Receives Consensus Recommendation of "Buy" from BrokeragesSio Gene Therapies Inc. (NASDAQ:SIOX) has received a consensus recommendation of "Buy" from the seven brokerages that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation and six have assigned a buy recommendationJanuary 5, 2022 | marketbeat.comCompanies Like Sio Gene Therapies (NASDAQ:SIOX) Are In A Position To Invest In GrowthJanuary 4, 2022 | nasdaq.comWe're Hopeful That Sio Gene Therapies (NASDAQ:SIOX) Will Use Its Cash WiselyNovember 12, 2021 | finance.yahoo.comGreat news for Sio Gene Therapies Inc. (NASDAQ:SIOX): Insiders acquired stock in large numbers last yearNovember 5, 2021 | nasdaq.comSio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 GangliosidosisNovember 1, 2021 | finance.yahoo.comSio Gene Therapies Gets FDA Fast-Track Designation for AXO-AAV-GM1 in GM1 Gangliosidosis >SIOXOctober 23, 2021 | marketwatch.comSio Gene Shares Gain As Genetic Nerve Cell Disorder Gene Therapy Trial Shows Encouraging ActionOctober 21, 2021 | msn.comSio Gene Therapies Announces Positive Interim Safety and Biomarker Data from Ongoing Phase 1/2 ...October 21, 2021 | apnews.comSio Gene Therapies Announces Positive Interim Safety and Biomarker Data from Ongoing Phase 1/2 Clinical Study of AXO-AAV-GM1 Gene Therapy in GM1 GangliosidosisOctober 21, 2021 | finance.yahoo.comSio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM1 (AAV9-GLB1) Gene Therapy in Patients with GM1 GangliosidosisOctober 21, 2021 | finance.yahoo.comSio Gene Therapies to Present New Data at the European Society of Gene and Cell Therapy Virtual Congress 2021October 4, 2021 | finance.yahoo.comUPDATE: Sio Gene Therapies to Present New Data at the European Society of Gene and Cell Therapy Virtual Congress 2021October 4, 2021 | finance.yahoo.comQuite a few insiders invested in Sio Gene Therapies Inc. (NASDAQ:SIOX) last year which is positive news for shareholdersSeptember 13, 2021 | finance.yahoo.comSio Gene Therapies Announces Dosing of First GM1 Gangliosidosis Early Infantile (Type I) Patient in Ongoing Phase 1/2 Study of AXO-AAV-GM1 Gene TherapySeptember 9, 2021 | finance.yahoo.comWhat Is The Ownership Structure Like For Sio Gene Therapies Inc. (NASDAQ:SIOX)?September 6, 2021 | nasdaq.comSio Gene Therapies Inc Shares Close in on 52-Week Low - Market MoverAugust 18, 2021 | nasdaq.comSio Gene Therapies Inc.August 5, 2021 | barrons.com Get Sio Gene Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIOX and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. SIOX Media Mentions By Week SIOX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SIOX News Sentiment▼0.000.48▲Average Medical News Sentiment SIOX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SIOX Articles This Week▼00▲SIOX Articles Average Week Get Sio Gene Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIOX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Clever Leaves News Grifols News LAVA Therapeutics News Mainz Biomed News Pharvaris News Procaps Group News Genprex News Aytu BioPharma News Enlivex Therapeutics News Oncolytics Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SIOX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sio Gene Therapies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sio Gene Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
